Fulcrum Therapeutics, Inc.

FULC · Healthcare · Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with gene…

Fulcrum Therapeutics, Inc. (FULC), in the Healthcare sector, has 7 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 2 purchases and 5 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jul 17 and filed Jul 21. The most active filer was Robert J Gould with 4 filings.

Add to watchlist

Filings, ttm

2 buys · 5 sells · 1 late

Traders, ttm

3 insiders

Volume, ttmiDollar value disclosed in the window

$60.5M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jul 17

Filed Jul 20

ADViAverage daily dollar volume

$9.2M

market data

Share price · 12M

$3.79 (-49.2%)

Adjusted for splits and dividends.

Volume by month

Buys $1.4M Sells $59.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Robert J Gould Director 4 filings KT

Kevin Tang Director 2 filings RL RA Capital Healthcare Fund LP Director 1 filing

Recent filings

Kevin TangPURCHASE 10% owner $595K
167,616 sh across 2 lots
Exec Jul 16
Filed Jul 20 · 9:10 PM ET Kevin TangPURCHASE 10% owner $845K
236,980 sh across 3 lots
Exec Jul 14
Filed Jul 15 · 7:50 PM ET Robert J GouldSALE Director $161K
15,000 sh × $10.72
Exec Feb 2
Filed Feb 4 · 5:30 PM ET Robert J GouldSALE Director $163K
15,000 sh × $10.87
Exec Jan 2
Filed Feb 4 · 5:30 PM ET † Robert J GouldSALE Director $178K
15,000 sh × $11.87
Exec Jan 2
Filed Jan 6 · 5:30 PM ET RA Capital Healthcare Fund LPSALE 10% owner $58.4M
4,175,139 sh across 3 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Robert J GouldSALE Director $165K
15,000 sh × $11.03
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET